These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 14733419)
21. Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism. Abdul Gafor AH; Saidin R; Loo CY; Mohd R; Zainudin S; Shah SA; Norella KC Nephrology (Carlton); 2009 Aug; 14(5):488-92. PubMed ID: 19298641 [TBL] [Abstract][Full Text] [Related]
22. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis. Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048 [TBL] [Abstract][Full Text] [Related]
23. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism. Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622 [TBL] [Abstract][Full Text] [Related]
24. [Low dosage intravenous calcitriol bolus therapy in chronic hemodialysis patients]. Neyer U; Wöss E; Drexel H Acta Med Austriaca; 1994; 21(5):129-32. PubMed ID: 7709710 [TBL] [Abstract][Full Text] [Related]
25. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats. Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Imazeki I; Kusano E; Shigematsu T; Akizawa T Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462 [TBL] [Abstract][Full Text] [Related]
26. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients. Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366 [TBL] [Abstract][Full Text] [Related]
27. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients. Liou HH; Chiang SS; Huang TP; Shieh SD; Akmal M Miner Electrolyte Metab; 1994; 20(3):97-102. PubMed ID: 7816008 [TBL] [Abstract][Full Text] [Related]
28. Intraoperative localization of parathyroid glands using methylthionine chloride / tetramethylthionine chloride in secondary hyperparathyroidism. Bland KI; Tidwell S; von Fraunhofer JA; Morris RR; McCoy MT; Wathen RL Surg Gynecol Obstet; 1985 Jan; 160(1):42-8. PubMed ID: 2578072 [TBL] [Abstract][Full Text] [Related]
29. Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients. Bajo MA; Selgas R; Possante C; Aguilera A; Sánchez C; Diaz C; de Alvaro F; Martinez ME Adv Perit Dial; 1997; 13():239-43. PubMed ID: 9360690 [TBL] [Abstract][Full Text] [Related]
30. Effects of calcitriol pulse therapy per os in CAPD patients. Scanziani R; Dozio B; Bonforte G; Surian M Adv Perit Dial; 1994; 10():270-4. PubMed ID: 7999844 [TBL] [Abstract][Full Text] [Related]
31. [Optical and ultrastructural morphology in hyperparathyroidism during dialysis]. Schiaffino E; Zogno C; Schmid C; Mangili F; Cantaboni A Pathologica; 1992; 84(1092):445-58. PubMed ID: 1491886 [TBL] [Abstract][Full Text] [Related]
32. A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients. Peng SJ; Yang CS; Ferng SH; Chen LY Miner Electrolyte Metab; 1997; 23(1):13-8. PubMed ID: 9058364 [TBL] [Abstract][Full Text] [Related]
33. [Intravenous calcitriol in the treatment of the refractory secondary hyperparathyroidism of terminal chronic kidney failure]. Almirall J; Torregrosa V; Arrizabalaga P; Cases A; Oliva J Med Clin (Barc); 1994 Mar; 102(9):325-8. PubMed ID: 8164458 [TBL] [Abstract][Full Text] [Related]
34. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism. Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420 [TBL] [Abstract][Full Text] [Related]
35. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis. Chow TL; Chan TT; Ho YW; Lam SH Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802 [TBL] [Abstract][Full Text] [Related]
36. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience]. Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031 [TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients. Capuano A; Serio V; Pota A; Memoli B; Andreucci VE J Nephrol; 2009; 22(1):59-68. PubMed ID: 19229819 [TBL] [Abstract][Full Text] [Related]
39. [Disorders of parathyroid function in patients on regular dialysis therapy and after kidney transplantation]. Sotorník I; Bubenícek P; Adamec M; Karasová L; Povýsil C; Skibová J Cas Lek Cesk; 2003; 142(4):229-34. PubMed ID: 12841126 [TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. Ljutić D; Cameron JS; Ogg CS; Turner C; Hicks JA; Owen WJ QJM; 1994 Nov; 87(11):685-92. PubMed ID: 7820543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]